Loading clinical trials...
Loading clinical trials...
Phase I Study of Probiotics as a Novel Approach to Modulate Gut Hormone Secretion and Risk Factors of Type 2 Diabetes and Complications
Conditions
Interventions
Lactobacillus reuteri
Locations
1
Germany
German Diabetes Center
Düsseldorf, Duesseldorf, Germany
Start Date
November 1, 2010
Primary Completion Date
December 1, 2011
Completion Date
December 1, 2011
Last Updated
July 29, 2011
NCT07472881
NCT01143454
NCT07051005
NCT07296484
NCT07010757
NCT06223555
Marie-Christine Simon, Dipl. oecotroph.
CONTACT
+49 211 3382marie-christine.simon@ddz.uni-duesseldorf.deLead Sponsor
German Diabetes Center
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions